Cargando…

Circular RNA as a Possible Novel Biomarker for Kawasaki Disease

Detalles Bibliográficos
Autor principal:	Yoon, Kyung Lim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Lipidology and Atherosclerosis 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379080/ https://www.ncbi.nlm.nih.gov/pubmed/32821698 http://dx.doi.org/10.12997/jla.2019.8.1.48

Ejemplares similares

Can iron be a risk factor for coronary lesions in Kawasaki disease?
por: Yoon, Kyung Lim
Publicado: (2019)

Kawasaki Disease and Hyponatremia
por: Kil, Hong Ryang
Publicado: (2010)

Update of genetic susceptibility in patients with Kawasaki disease
por: Yoon, Kyung Lim
Publicado: (2015)

The Platelet microRNA Profile of Kawasaki Disease: Identification of Novel Diagnostic Biomarkers
por: Ning, Qianqian, et al.
Publicado: (2020)

Factors Predicting Resistance to Intravenous Immunoglobulin and Coronary Complications in Kawasaki Disease: IVIG Resistance in Kawasaki Disease
por: Han, Ji Whan
Publicado: (2017)

Kawasaki Disease in Adulthood
por: Hammad, Basma, et al.
Publicado: (2021)

Analysis of Circular RNAs in the Coronary Arteries of Patients with Kawasaki Disease
por: Kim, Young-Kook
Publicado: (2019)

Consortium-Based Genetic Studies of Kawasaki Disease in Korea: Korean Kawasaki Disease Genetics Consortium
por: Lee, Jong-Keuk, et al.
Publicado: (2015)

Kawasaki Disease, MIS-C and COVID-19
por: Huang, Ying-Hsien, et al.
Publicado: (2023)

Serum Ferritin as a Diagnostic Biomarker for Kawasaki Disease
por: Kim, Sung Hoon, et al.
Publicado: (2021)

Circular RNA: A novel type of biomarker for glioma
por: Sun, Wei, et al.
Publicado: (2021)

Does any specific infection cause Kawasaki disease?
por: Lee, Dong Seok
Publicado: (2019)

Recent research trends in Kawasaki disease-related infection
por: Woo, Hyang-Ok
Publicado: (2022)

Infliximab, Is It Really a New Horizon for the Treatment of Kawasaki Disease?
por: Eun, Lucy Youngmin
Publicado: (2019)

Risk Factors for Failure of Initial Intravenous Immunoglobulin Treatment in Kawasaki Disease
por: Cha, Sungho, et al.
Publicado: (2008)

Novel data-mining approach identifies biomarkers for diagnosis of Kawasaki disease
por: Tremoulet, Adriana H., et al.
Publicado: (2015)

The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?
por: Han, Ji Whan
Publicado: (2017)

Another compelling evidence suggesting infectious diseases as the cause of Kawasaki disease?
por: Lai, Chou-Cheng
Publicado: (2020)

Predictive risk factors of coronary artery aneurysms in Kawasaki disease
por: Woo, Hyang-Ok
Publicado: (2019)

Risk Factors Related to Coronary Artery Outcome in Kawasaki Disease
por: Kim, Soo-Jin
Publicado: (2018)

Circular RNA as a Novel Biomarker and Therapeutic Target for HCC
por: Meng, Hongwu, et al.
Publicado: (2022)

Kawasaki Disease and Infections: A Myth or a Reality?
por: Gupta, Anju
Publicado: (2022)

Possible Involvement of Infection with Human Rhinoviruses in Children with Kawasaki Disease
por: Li, Ya-wei, et al.
Publicado: (2023)

Understanding Kawasaki Disease on the Ground of Pediatric Growth and Lymphoid Tissue Maturation
por: Oh, Jin-Hee
Publicado: (2017)

Can the accurate epidemiological study help to search the etiology of Kawasaki disease?
por: Han, Ji Whan
Publicado: (2020)

An Unintended Consequence of Pandemic Control Measures: Fewer Cases of Kawasaki Disease
por: Shulman, Stanford T., et al.
Publicado: (2021)

Characteristics of z score systems for diagnosing coronary abnormalities in Kawasaki disease
por: Yoo, Gyeong-Hee
Publicado: (2022)

Infliximab Treatment for Refractory Kawasaki Disease in Korean Children
por: Song, Min Seob, et al.
Publicado: (2010)

The Usefulness of Platelet-derived Microparticle as Biomarker of Antiplatelet Therapy in Kawasaki Disease
por: Kim, Hyun Jung, et al.
Publicado: (2017)

Circular RNAs: An emerging type of RNA in cancer
por: Hou, Li-Dan, et al.
Publicado: (2017)

Long-Term Outcome of Kawasaki Disease Complicated by a Large Coronary Aneurysm
por: Jung, Jo Won
Publicado: (2017)

Clinical characteristics of hemophagocytic lymphohistiocytosis following Kawasaki disease: differentiation from recurrent Kawasaki disease
por: Kang, Hae-Ryong, et al.
Publicado: (2013)

Anemia in Kawasaki Disease: Hepcidin as a Potential Biomarker
por: Huang, Ying-Hsien, et al.
Publicado: (2017)

Circular RNA: a novel biomarker and therapeutic target for human cancers
por: Lei, Bo, et al.
Publicado: (2019)

Diagnostic Applications for Clinical and Imaging Data in Kawasaki Disease with Lymphadenopathy-First-Presentation
por: Son, Jae Sung
Publicado: (2018)

Could Immunoglobulin Level Be a Prognostic Factor for Coronary Artery Lesions in Kawasaki Diseases?
por: Han, Mi Young
Publicado: (2021)

Circular RNAs: Novel Promising Biomarkers in Ocular Diseases
por: Guo, Nan, et al.
Publicado: (2019)

Circular RNAs: Biogenesis, Function, and a Role as Possible Cancer Biomarkers
por: Bolha, Luka, et al.
Publicado: (2017)

Circular RNA Methylation: A New Twist in Lung Fibrosis
por: Ligresti, Giovanni, et al.
Publicado: (2022)

Biomarkers for Kawasaki Disease: Clinical Utility and the Challenges Ahead
por: Chaudhary, Himanshi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o4u68msi0lejas8ih35ndquv3r